Log in or subscribe to view full content. Article is also available for purchase the article in one of the available formats.
Feeds
188549 items (188549 unread) in 47 feeds
World Health Organization
(225 unread)
-
WHO news (100 unread)
-
Media
(145921 unread)
-
Reuters Health eLine
(2178 unread)
-
CNN Health (2217 unread)
-
NYT > Health (4495 unread)
-
NPR Health and Science (2942 unread)
-
ABC News: Health (6817 unread)
-
CBSnews.com: Health News (7921 unread)
-
BBC Health News (3337 unread)
-
CBC Health and Science News (2744 unread)
-
Australia ABC News: Health
(4827 unread)
-
China Xinghua Health News
(30 unread)
-
New York Times: Health
(6881 unread)
-
USATODAY.com Health - Top Stories (4374 unread)
-
The Seattle Times: Health (5822 unread)
-
International Herald Tribune: Health and Science (6837 unread)
-
HeraldToday.com: Health
-
WebMD Health Headlines
(5169 unread)
-
MedicineNet Daily News (9206 unread)
-
Medical News Today
(39217 unread)
-
iVillage Health
(5376 unread)
-
Topix.net - Health (5468 unread)
-
Newsvine - health
(20063 unread)
Bird Flu
(3037 unread)
-
MSNBC.com: Bird Flu (14 unread)
-
-
Medical News Today - Bird Flu/Avian Flu
(110 unread)
-
Diabetes
(8383 unread)
-
-
Medical News Today - Diabetes
(2192 unread)
-
Cholesterol
(3552 unread)
-
Topix.net - Cholesterol
(2022 unread)
-
Medical News Today - Cholesterol
(372 unread)
-
Cancer
(15070 unread)
-
-
-
Medical News Today - Breast Cancer News
(1719 unread)
-
Medical News Today - Cancer/Oncology News
(5797 unread)
-
HIV
(7233 unread)
-
-
Medical News Today - HIV/AIDS News
(1907 unread)
-
Women
(3799 unread)
-
-
Medical News Today - OBGYN News
(2583 unread)
-
Men
(1329 unread)
-
-
Medical News Today - Men's health News
(626 unread)
-
Topix.net - Cholesterol (50 unread)
-
Combination Treatment with Atorvastatin Plus Niacin Provides...
Posted: February 6th, 2012, 8:31pm CST
-
Santarus Inc. Begins Promoting Cholesterol-Lowering Product FENOGLIDE
Posted: February 6th, 2012, 4:21pm CST
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia SAN DIEGO-- --Santarus, Inc.
-
MYTH: Stress Tests and Cholesterol Screenings determine Heart Disease Risks
Posted: February 6th, 2012, 11:12am CST
When I was getting my degree in exercise science, one of the things we learned how to do is an exercise stress test with an ECG .
-
Dark chocolate and red wine are the heart-healthy food, drink of love
Posted: February 6th, 2012, 9:12am CST
Forget the oysters and the champagne this Valentine's Day. If you want to keep your true love's heart beating strong, dark chocolate and red wine are the food and drink of love, said Susan Ofria, clinical nutrition manager at Gottlieb Memorial Hospital.
-
Health News: Ask the Experts
Posted: February 6th, 2012, 12:58am CST
I'm aged 43 and have been taking simvastatin for seven months due to high cholesterol.
-
Generic drugs provide benefits for all
Posted: February 4th, 2012, 6:27am CST
Most of us can recognize the difference between a brand name product and a non-brand named or generic product.
-
You Have to Know the High Cholesterol Symptoms
Posted: February 4th, 2012, 2:12am CST
You have to know the high cholesterol symptoms as it is very important for you. Cholesterol is such a nutrition element, which is needed for the proper growth of a human body.
-
High bad cholesterol, low gooda
Posted: February 3rd, 2012, 7:03pm CST
Q: High bad cholesterol, low good cholesterol, Off Lipitor due to severe loss of muscle, what foods or supplements should I take? Important: We hope you find this general health information helpful.
-
Generic version of Lipitor receives tentative FDA approval
Posted: February 3rd, 2012, 3:53pm CST
On February 2, 2012, Mylan Inc. announced the tentative U.S. Food and Drug Administration approval of Atorvastatin Calcium.
-
Merck & Co. swings to Q4 profit on lower charges
Posted: February 3rd, 2012, 1:09am CST
Merck & Co. swung to a fourth-quarter profit because of lower restructuring and other charges and higher sales of most of its key drugs.
-
It's 'Buyer Beware' When Getting Statins Off the Internet
Posted: February 2nd, 2012, 9:00pm CST
THURSDAY, Feb. 2 -- Be wary of buying the cholesterol-lowering drugs known as statins on the Internet, British researchers say.
-
AstraZeneca: short-term syndrome
Posted: February 2nd, 2012, 4:56pm CST
The bottom line is usually the one to watch. But not for AstraZeneca. On Thursday, the British drug maker announced a 7 per cent increase in earnings per share before exceptional items.
-
Pharmaceutical Industry Earnings 4Q: Pfizer, Eli Lilly Hit Hard, Merck is Next
Posted: February 2nd, 2012, 12:41pm CST
Merck & Co. Inc. is set to take such a hit in the second half of 2012. and Lilly, which reported steep declines in their fourth-quarter profits, experienced the initial impact from generics since they lost U.S. patent protection on several of their top-selling treatments.
-
Mylan gets tentative Fda Ok for generic Lipitor
Posted: February 2nd, 2012, 11:36am CST
Generic drugmaker Mylan Inc. said Thursday that the Food and Drug Administration tentatively approved several pill sizes of the company's generic version of cholesterol fighter Lipitor, the world's top-selling drug.
-
Beef can taste great and be heart healthy as well
Posted: February 2nd, 2012, 1:02am CST
February is American Heart Month. For many years doctors and nutritionists have preached to cut red meat from the diet to improve heart health, but now new research shows that a moderate amount of lean beef is not only acceptable, but actually beneficial.
-
Lipitor foreshadows approaching patent cliff for other leading drugs
Posted: February 1st, 2012, 2:38pm CST
For the past several years, drug industry experts have spoken in terms of the "patent cliff," the period when the patents covering several blockbuster drugs are set to expire, thus leaving their manufacturers with a big, gaping hole in their revenues as those drugs face competition from generics.
-
Full Commentary
Posted: February 1st, 2012, 9:23am CST
More News in Brief: CT-Scan Dye Can Affect Thyroid; Sex Called Safe for Most Heart Patients; Safety of New Blood Thinner Gets a Closer Look Osteoporosis is a disease that causes bones to become "thin" . It can lead to hip fractures and spine fractures in elderly people.
-
Preliminary results from CINJ's Celebrex and Lipitor Phase II combination trial on prostrate cancer
Posted: February 1st, 2012, 5:19am CST
Research from The Cancer Institute of New Jersey on the FDA-approved drugs Celebrex A and Lipitor A -- used respectively for arthritis pain and lowering cholesterol -- shows that these drugs are well tolerated in the treatment of recurrent prostate cancer .
-
Pfizer Reports 6 Percent Rise in Quarterly Earnings
Posted: February 1st, 2012, 1:14am CST
Pfizer Inc., issuing its first financial report since losing patent protection on blockbuster cholesterol drug Lipitor, said today that adjusted earnings in the fourth quarter rose 6 percent.
-
New study reveals statins work as well for women as men
Posted: January 31st, 2012, 8:59pm CST
Doctors are more likely to give cholesterol drugs known as statins to men. But a new study, published in the Jan.
-
Summary Box: Charges, generics hurt Pfizer's 4Q
Posted: January 31st, 2012, 4:55pm CST
PROFIT DIVE: Drugmaker Pfizer's fourth-quarter net income fell by half, to $1.44 billion, or 19 cents per share, because of charges and new generic competition for Lipitor, the blockbuster cholesterol-lowering drug.
-
Earnings Preview: Merck report keys on new drugs
Posted: January 31st, 2012, 12:45pm CST
Drugmaker Merck & Co., the world's third-biggest drugmaker by revenue and a Dow component, will tout recent drug approvals and progress on creating new drugs when it reports its fourth-quarter results before the stock market opens Thursday.
-
Pfizer 4Q net falls by half after generic Lipitor
Posted: January 31st, 2012, 8:41am CST
Pfizer Inc. said Tuesday that its fourth-quarter profit fell by half due to one-time charges and a drop in U.S. revenue, which was hurt by blockbuster cholesterol drug Lipitor losing patent protection.
-
Pfizer trims 2012 view, citing stronger dollar
Posted: January 31st, 2012, 8:41am CST
A view of the Belgian headquarters of U.S. pharmaceutical giant Pfizer, in Brussels in this January 23, 2007 file photo.
-
Drugmaker Pfizer's Q4 net income falls by half on charges, US arrival of generic Lipitor
Posted: January 31st, 2012, 6:36am CST
Pfizer Inc.'s fourth-quarter profit fell by half due to one-time charges and a drop in U.S. revenue, which was hurt by blockbuster cholesterol drug Lipitor losing patent protection.
-
Paul Donohue: Be cautious if you stop taking meds
Posted: January 31st, 2012, 12:21am CST
Dear Dr. Donohue: I am a 69-year-old woman and take simvastatin and alendronate.
-
Statins Equally Effective in Women and Men
Posted: January 30th, 2012, 4:07pm CST
MONDAY, Jan. 30 -- Cholesterol-lowering drugs known as statins are equally effective in men and women, a new study finds.
-
Investors to watch forecasts as drug makers' key patents expire
Posted: January 29th, 2012, 7:34pm CST
Both companies have to grapple with the expiration this year of patents on their largest products.
-
White Lightning for Breakfast?
Posted: January 28th, 2012, 7:27pm CST
When one reads the above statement, moonshine may be the first thing that comes to mind, prompting them to ask, "Why would a Registered Dietitian suggest moonshine for breakfast?" White lighting was a brand of cider brewed by Scottish Courage in the UK from the early 1900s until 2009.
-
Earnings Preview: Pfizer to report on 4th quarter
Posted: January 28th, 2012, 1:17pm CST
TRENTON, N.J. — Pfizer Inc., which reports fourth-quarter results before the stock market opens Tuesday, will tout two recent drug approvals, discuss a couple of other drugs awaiting approval and outline its revenue prospects now that it has generic competition to cholesterol blockbuster Lipitor.
-
Drug Watch: First Combination Drug for Type 2 Diabetes and Hyperlipidemia
Posted: January 28th, 2012, 9:07am CST
It combines the anti-hyperglycemic drug sitagliptin with the antilipid drug simvastatin .
-
FDA approves Pfizer's Inlyta for kidney cancer
Posted: January 28th, 2012, 4:53am CST
Pfizer's Inlyta drug for patients with advanced kidney cancer got the nod from U.S. regulators on Friday, boosting the company's plans to offset plunging Lipitor sales.
-
Lowering your cholesterol, with or without statins
Posted: January 28th, 2012, 12:49am CST
Sharon Weems did something in 2009 that most Americans in her situation can't seem to manage: She lowered her cholesterol significantly, and without the help of medication.
-
Express Scripts' Lipitor Move Highlights Pressure On Pfizer
Posted: January 27th, 2012, 8:34pm CST
Pharmacy-benefit manager Express Scripts Inc. will soon make an adjustment that raises out-of-pocket costs for some customers filling prescriptions of Pfizer Inc.'s cholesterol-lowering drug Lipitor, underscoring the drug maker's challenge of keeping sales high in the face of generic competition.
-
Earnings Preview For Pfizer Q4 2011
Posted: January 27th, 2012, 4:19pm CST
Pfizer is scheduled to report 4Q 2011 earnings before the opening bell on Tuesday, January 31.
-
preventing further health problems with diabetes.
Posted: January 27th, 2012, 12:05pm CST
If you have diabetes, there are many ways to guard your health. Your efforts will help to control diabetes.
-
Zocor Recall Overview
Posted: January 26th, 2012, 8:41pm CST
Simvastatin is a drug marketed under the brand name of Zocor by Merck & Co.A Zocor and its generics are used to regulate high cholesterol in those who cannot control their cholesterol level through diet and exercise alone.
-
US seeks injunction on Indian drug firm...
Posted: January 25th, 2012, 10:28pm CST
US officials sought a "groundbreaking" injunction Wednesday against Indian pharmaceutical giant Ranbaxy, saying the maker of the first generic version of a cholesterol-lowering drug has failed to meet US safety guidelines.
-
Abbott Slips as Fourth-Quarter Sales Come in Below Estimates
Posted: January 25th, 2012, 3:14pm CST
Abbott Laboratories, the health-care company that plans to spin off its drug business, fell the most in two months after reporting fourth-quarter sales that came in below analyst estimates.
-
Merck & Co., Inc.'s Cholesterol Drug Vytorin to Get New Label
Posted: January 25th, 2012, 11:10am CST
In SHARP, VYTORIN 10/20 mg lowered LDL cholesterol in patients with moderate to severe chronic kidney disease , and major vascular events were reduced in the treatment group compared to placebo.
-
UPDATE 1-Merck's cholesterol drug Vytorin to get new label
Posted: January 25th, 2012, 9:05am CST
Merck said the U.S. health regulator approved an updated label for its cholesterol treatment Vytorin to show that the drug effectively lowered bad cholesterol in patients with a kidney disease, and reduced the risk of vascular events.
-
Medication Update
Posted: January 25th, 2012, 5:00am CST
The Nurse Practitioner: The American Journal of Primary Health Care February 2012 Volume 37 Number 2 Pages 56 - 56 The FDA notified healthcare professionals that the cholesterol-lowering medication fenofibric acid may not lower a patient's risk of myocardial infarction or stroke.
-
Pfizer's Lipitor Plan Against Copies May Not Be - Worth It' Watson CEO Says
Posted: January 24th, 2012, 2:21pm CST
Pfizer Inc. 's strategy to keep its market share of cholesterol pill Lipitor may boost revenue without aiding profit, said the chief executive officer of Watson Pharmaceuticals Inc.
-
House - Episode 9 (Season 8): "Better Half"
Posted: January 23rd, 2012, 11:42pm CST
Andres is a man with early onset Alzheimer's disease . He is being evaluated for possible inclusion in a drug study when he develops bloody vomiting .
-
Statins May Join Fight Against Breast Cancer
Posted: January 23rd, 2012, 11:13am CST
For breast cancer patients with a p53 genetic mutation may someday start taking statins -- drugs that lower cholesterol -- to help fight their disease.
-
New Questions and Answers on Lipitor, the Most Prescribed Brand Name Drug in America
Posted: January 22nd, 2012, 10:45am CST
When patents expire on profitable brand-name prescription drugs, patients and their insurance companies usually both catch a break on the price as generic manufacturers move in with cheaper versions of the same drug.
-
The Grapefruit Active Lifestyle Meal Plan: Should You Try It?
Posted: January 21st, 2012, 2:59am CST
Grapefruit is a superstar among superfoods . Just one grapefruit packs more than 100 percent of the daily recommended serving of Vitamin C. Additionally, lycopene, the pigment that gives grapefruit its pink color, is linked to protection against heart disease, breast cancer, and prostate cancer, and it's been shown to help lower your "bad" LDL ... (more)
-
Watson Increases Generic Count - Analyst Blog
Posted: January 20th, 2012, 10:47pm CST
Watson Pharmaceuticals Inc. added another drug to its list of generic launches as it announced the launch of Vestura, the generic version of Bayer 's oral contraceptive, Yaz.
-
Challenges and opportunities abound as generic wave hits the shore
Posted: January 20th, 2012, 6:33pm CST
WHAT IT MEANS AND WHY IT'S IMPORTANT - One analysis report after another seems to confirm that the generic drug market is in for a huge shift as the number of blockbuster drugs losing patent protection is set to dwindle over the next several years.
-
Pfizer: A Good Defensive Stock Pick
Posted: January 20th, 2012, 2:01pm CST
Pfizer Inc. is the world's largest biopharmaceutical company. The company provides healthcare and drug products and services through two segments: biopharmaceutical segment and diversified segment.